Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.574

-4.3%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	6/18/2008 4:32:54 PM
	Read Replies (1) of 368

Hot Stocks story about SGMO, DOW Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (DOW), announced that it has exercised its option to obtain a commercial license to zinc finger technology from Richmond, Calif.-based Sangamo BioSciences (SGMO). The license allows Dow AgroSciences to commercialize products incorporating or developed from plant cells using Sangamo's zinc finger DNA-binding protein technology, in agricultural crops, industrial products and plant-derived biopharmaceuticals. :thefly

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next